Segovia, Romeo C.
HRN: 24-70-45 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2024
FLUCONAZOLE 50MG (CAP)
04/03/2024
04/06/2024
PO
50mgtab; 2 Tabsfor 10 Days
Q24
Oral Candidiasis
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes